Strength
150; 300 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722050660
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
LAMIVUDINE; ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA079124On Market Since
9/18/2015
Pharmacological Classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
NEVIRAPINE 200 MG TABLET
Generic
65862002760•Aurobindo Pharma Limited
$0.1314
per EA
NEVIRAPINE 200 MG TABLET
Generic
00378405091•Mylan Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
31722050560•Camber Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
33342000409•Macleods Pharmaceuticals Limited
$0.1472
per EA
ZIDOVUDINE 50 MG/5 ML SYRUP
Generic
65862004824•Aurobindo Pharma Limited
$0.1499
per ML
NEVIRAPINE 200 MG TABLET
Generic
65162020906•Amneal Pharmaceuticals LLC
$0.1556
per EA
ENTECAVIR 0.5 MG TABLET
Generic
16714071701•NorthStar Rx LLC
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083330•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083390•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42494045730•Cameron Pharmaceuticals
$0.2110
per EA